BIOGENA Expands into Turkey: BIOGENA ONE Launches with a Strong Local Partner Team

Salzburg, May 7, 2026. Austrian health brand BIOGENA continues its international growth journey with the official launch of BIOGENA ONE in Turkey. The company has signed an official distribution agreement with local entrepreneurs and partners Mert Dorman and Enes Bakan.

With a population of more than 85 million, a young urban demographic, and rapidly growing awareness of health and well-being, Turkey is one of BIOGENA's most strategically important growth markets at the crossroads of Europe and Asia.

For BIOGENA, Turkey is far more than just a new sales market. The company sees several powerful trends converging: increasing purchasing power, rapid digitalization and consumer market growth, and a rising interest in preventive healthcare, modern health solutions, and personal well-being.

"Turkey represents a market with enormous future potential. We see a rapidly growing awareness of prevention, health, and holistic well-being. What unites us with our local partners is not only entrepreneurial ambition, but above all a shared vision: to rethink health and sustainably improve people's quality of life," says Dr. Albert Schmidbauer, Founder and CEO of BIOGENA.

With BIOGENA ONE, the company pursues a holistic approach to modern preventive healthcare. The focus lies on practical everyday health solutions, scientifically backed products, and a scalable platform designed to meet the needs of diverse target groups.

BIOGENA deliberately relies on strong local partnerships to drive its international expansion. Together with its Turkish partner team led by Mert Dorman, Managing Director of BIOGENA ONE Turkey and former senior executive at Turkish Airlines, and Enes Bakan, Managing Director of the Bakan family business and Founding Partner of the Turkish project, who also maintains business operations in Austria, BIOGENA ONE aims to establish a long-term and sustainable presence in the Turkish market.

Mert Dorman brings an exceptionally strong network across Turkey's business, healthcare, and longevity sectors and is regarded as one of the country's best-connected executives. Combined with the entrepreneurial expertise of the Bakan family—active in the food industry for nearly 50 years and renowned as a traditional producer of premium olives and olive oil in Turkey and across Europe—the partnership provides a solid foundation for a successful market entry.

"We are proud to build BIOGENA together in Turkey. The combination of scientifically backed products, premium quality, and a modern understanding of health perfectly meets the needs of a market that is increasingly embracing prevention and conscious living. Our goal is to make health easily accessible while building long-term trust," say Mert Dorman, Managing Director of BIOGENA ONE Turkey, and Enes Bakan, Managing Director of the Bakan family business and Founding Partner of the project.

On BIOGENA's side, the project has been supported by several key team members, including Martin Gratzer (CEO of BIOGENA ONE), Margit Loidl (Head of Global Sales B2B and Managing Director), and Fabian Haberle (Head of International Sales at BIOGENA).

With its market entry into Turkey, BIOGENA continues to consistently expand its international presence. The company views the new market as another important milestone in its long-term growth strategy, with further international expansion already in the pipeline.